Literature DB >> 31049337

Subclinical Onychomycosis: Not Present in HIV-Positive Population?

Claudia Contreras-Rivera1, Sonia Toussaint-Caire2, Ramón Fernández-Martínez1, Gabriela Moreno-Coutiño1.   

Abstract

BACKGROUND: Onychomycosis is one of the most common nail diseases and constitutes up to 50% of all nail conditions. It is a chronic fungal nail infection common in the HIV-infected population. Few studies have found fungal organisms in the nail without clinical evidence, and thus, termed subclinical onychomycosis.
OBJECTIVES: We analyzed the nails of the HIV population in our hospital, searching for subclinical onychomycosis.
METHOD: A distal nail clipping was stained with PAS and observed by a trained dermatopathologist.
RESULTS: All of our samples (n = 48) turned out to be negative for fungal structures.
CONCLUSIONS: The epidemiology of onychomycosis is changing, treatment options are much better now, and diagnosis and infection detection are being done earlier. Therefore, we will continue to further study this disease in other patient populations so that we can compare our results and see whether the incidence of onychomycosis in the HIV population is now similar to that in those without HIV infection of the same age.

Entities:  

Keywords:  HIV-positive patients; Nail disease; Subclinical onychomycosis

Year:  2018        PMID: 31049337      PMCID: PMC6489040          DOI: 10.1159/000494459

Source DB:  PubMed          Journal:  Skin Appendage Disord        ISSN: 2296-9160


  9 in total

1.  Evaluation of improvement of onychomycosis in HIV-infected patients after initiation of combined antiretroviral therapy without antifungal treatment.

Authors:  Patricia Ruíz-López; Gabriela Moreno-Coutiño; Ramón Fernández-Martínez; Jessica Espinoza-Hernández; Patricia Rodríguez-Zulueta; Gustavo Reyes-Terán
Journal:  Mycoses       Date:  2015-07-07       Impact factor: 4.377

2.  Why should we care if onychomycosis is truly onychomycosis?

Authors:  R J Hay; R Baran
Journal:  Br J Dermatol       Date:  2015-02       Impact factor: 9.302

3.  Improvement in onychomycosis after initiation of combined antiretroviral therapy.

Authors:  Gabriela Moreno-Coutiño; Roberto Arenas; Gustavo Reyes-Terán
Journal:  Int J Dermatol       Date:  2012-09-24       Impact factor: 2.736

4.  PAS is optimal for diagnosing onychomycosis.

Authors:  Orr Barak; Adam Asarch; Thomas Horn
Journal:  J Cutan Pathol       Date:  2010-04-12       Impact factor: 1.587

5.  The prevalence of dermatophyte infection in patients infected with human immunodeficiency virus.

Authors:  Graham E J Rodwell; Charlene L Bayles; Loan Towersey; Raza Aly
Journal:  Int J Dermatol       Date:  2008-04       Impact factor: 2.736

6.  When is onychomycosis onychomycosis? A cross-sectional study of fungi in normal-appearing nails.

Authors:  A Shemer; A K Gupta; R Farhi; D Daigle; B Amichai
Journal:  Br J Dermatol       Date:  2014-12-10       Impact factor: 9.302

7.  Subclinical onychomycosis is associated with tinea pedis.

Authors:  H W Walling
Journal:  Br J Dermatol       Date:  2009-06-24       Impact factor: 9.302

8.  Clinical presentation of onychomycosis in hiv/aids: a review of 280 mexican cases.

Authors:  Gabriela Moreno-Coutiño; Roberto Arenas; Gustavo Reyes-Terán
Journal:  Indian J Dermatol       Date:  2011-01       Impact factor: 1.494

9.  Subclinical Onychomycosis in Patients With Type II Diabetes.

Authors:  Amira Elbendary; Amira El Tawdy; Naglaa Zaki; Mostafa Alfishawy; Amr Rateb
Journal:  Dermatol Reports       Date:  2015-12-17
  9 in total
  2 in total

1.  Nail Changes in People Living with Human Immunodeficiency Virus: Observational and Cross-Sectional Study in a Third-Level Hospital.

Authors:  Luis R Flores-Bozo; Silvia Méndez-Flores; Valeria Olvera-Rodríguez; Josune Echevarría-Keel; Lilly Esquivel-Pedraza; Andrea Rangel-Cordero; Pablo F Belaunzarán-Zamudio; Judith G Domínguez-Cherit
Journal:  Skin Appendage Disord       Date:  2022-04-22

2.  Subclinical Onychomycosis in Apparently Healthy Adults.

Authors:  Alejandra Angulo-Rodríguez; Heidi Hernández-Ramírez; María Elisa Vega-Memije; Sonia Toussaint-Caire; Gabriela Moreno-Coutiño
Journal:  Skin Appendage Disord       Date:  2021-02-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.